Screening for non-alcoholic fatty liver disease in type 2 diabetes using non-invasive scores and association with diabetic complications

Screening for non-alcoholic fatty liver disease in type 2 diabetes using non-invasive scores and association with diabetic complications

ObjectiveNon-alcoholic fatty liver disease (NAFLD) is prevalent in patients with type 2 diabetes. Here, we estimate the proportion of patients with type 2 diabetes that should be referred to hepatologists according to the European Association for the Study of the Liver (EASL)-European Association fo...

Full description

Bibliographic Details
Main Authors: Stefano Ciardullo, Emanuele Muraca, Silvia Perra, Eleonora Bianconi, Francesca Zerbini, Alice Oltolini, Rosa Cannistraci, Paola Parmeggiani, Giuseppina Manzoni, Guido Lattuada, Gianluca Perseghin
Format: Article
Language:English
Published: BMJ Publishing Group 2020-04-01
Series:BMJ Open Diabetes Research & Care
Online Access:https://drc.bmj.com/content/8/1/e000904.full

Internet

https://drc.bmj.com/content/8/1/e000904.full

Similar Items